Neuronetics (STIM) News Today $3.79 +0.02 (+0.53%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent DepressionApril 2, 2025 | msn.comNeuronetics announces Evernorth Health expanded its coverage of NeuroStar TMSMarch 31, 2025 | markets.businessinsider.comNeuronetics, Inc. (NASDAQ:STIM) Short Interest Up 39.7% in MarchNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 2,780,000 shares, a growth of 39.7% from the February 28th total of 1,990,000 shares. Approximately 10.2% of the shares of the company are sold short. Based on an average daily volume of 1,440,000 shares, the days-to-cover ratio is currently 1.9 days.March 31, 2025 | marketbeat.comEvernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with DepressionMarch 31, 2025 | globenewswire.comNeuronetics: Explosive Growth Poised To Soar On FDA BreakthroughsMarch 30, 2025 | seekingalpha.comNeuronetics Revises Financial Results for Q4 and Full Year 2024March 29, 2025 | msn.comWilliam Blair Keeps Their Hold Rating on Neuronetics (STIM)March 28, 2025 | markets.businessinsider.comNeuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating ResultsMarch 27, 2025 | globenewswire.comThis Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From HereMarch 25, 2025 | msn.comWhile private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownershipMarch 23, 2025 | finance.yahoo.comNeuronetics, Inc. (NASDAQ:STIM) Sees Significant Increase in Short InterestNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the recipient of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,990,000 shares, an increase of 24.4% from the February 13th total of 1,600,000 shares. Based on an average trading volume of 1,330,000 shares, the short-interest ratio is presently 1.5 days. Currently, 7.3% of the shares of the company are sold short.March 18, 2025 | marketbeat.comWilliam Blair Forecasts Increased Earnings for NeuroneticsNeuronetics, Inc. (NASDAQ:STIM - Free Report) - Equities research analysts at William Blair boosted their Q1 2025 EPS estimates for Neuronetics in a research report issued to clients and investors on Wednesday, March 5th. William Blair analyst M. Andrew now forecasts that the company will post eaMarch 8, 2025 | marketbeat.comNeuronetics (NASDAQ:STIM) Given New $8.00 Price Target at Canaccord Genuity GroupCanaccord Genuity Group raised their target price on Neuronetics from $5.00 to $8.00 and gave the company a "buy" rating in a report on Wednesday.March 6, 2025 | marketbeat.comNeuronetics price target raised to $8 from $5 at CanaccordMarch 5, 2025 | markets.businessinsider.comNeuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call TranscriptMarch 5, 2025 | msn.comNeuronetics price target raised to $7 from $3 at Citizens JMPMarch 5, 2025 | markets.businessinsider.comNeuronetics Shares Rise in Premarket on Rosy Growth OutlookMarch 4, 2025 | marketwatch.comNeuronetics reports Q4 EPS (33c), consensus (24c)March 4, 2025 | markets.businessinsider.comNeuronetics, Inc. (STIM) Q4 2024 Earnings Call TranscriptMarch 4, 2025 | seekingalpha.comNeuronetics (NASDAQ:STIM) Issues Earnings Results, Misses Expectations By $0.07 EPSNeuronetics (NASDAQ:STIM - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.07). Neuronetics had a negative net margin of 50.09% and a negative return on equity of 141.24%.March 4, 2025 | marketbeat.comNeuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating ResultsMarch 4, 2025 | globenewswire.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)March 3, 2025 | globenewswire.comNeuronetics (STIM) Projected to Post Quarterly Earnings on TuesdayNeuronetics (NASDAQ:STIM) will be releasing earnings before the market opens on Tuesday, March 4. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669079)February 25, 2025 | marketbeat.comNeuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy NowFebruary 23, 2025 | msn.comNeuronetics to Announce Q4 2024 Results on March 4, 2025February 22, 2025 | msn.comNeuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference CallFebruary 21, 2025 | markets.businessinsider.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 17,307 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 17,307 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $4.11, for a total value of $71,131.77. Following the completion of the transaction, the chief financial officer now owns 454,420 shares in the company, valued at approximately $1,867,666.20. This trade represents a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 19, 2025 | marketbeat.comStephen Furlong Sells 17,307 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockFebruary 19, 2025 | insidertrades.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CFO Sells 10,845 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 10,845 shares of the stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $3.83, for a total transaction of $41,536.35. Following the transaction, the chief financial officer now owns 471,727 shares of the company's stock, valued at $1,806,714.41. This trade represents a 2.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.February 15, 2025 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) EVP Sells $46,630.25 in StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) EVP William Andrew Macan sold 12,175 shares of the company's stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $3.83, for a total value of $46,630.25. Following the sale, the executive vice president now owns 388,647 shares of the company's stock, valued at $1,488,518.01. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.February 15, 2025 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) CFO Stephen Furlong Sells 10,845 SharesFebruary 15, 2025 | insidertrades.comNeuronetics EVP William Andrew Macan sells $46,630 in stockFebruary 14, 2025 | msn.comNeuronetics CFO Stephen Furlong sells $41,536 in stockFebruary 14, 2025 | msn.comNeuronetics CFO Stephen Furlong sells shares worth $48,662February 13, 2025 | msn.comNeuronetics, Inc. (NASDAQ:STIM) CFO Stephen Furlong Sells 14,836 SharesFebruary 13, 2025 | insidertrades.comNeuronetics' EVP William Andrew Macan sells $6,461 in stockFebruary 13, 2025 | msn.comNeuronetics CEO Keith Sullivan sells $134,453 in stockFebruary 13, 2025 | msn.comStephen Furlong Sells 14,836 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CFO Stephen Furlong sold 14,836 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $48,662.08. Following the completion of the transaction, the chief financial officer now directly owns 482,572 shares in the company, valued at approximately $1,582,836.16. The trade was a 2.98 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.February 12, 2025 | marketbeat.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 40,992 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) CEO Keith J. Sullivan sold 40,992 shares of the firm's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $3.28, for a total transaction of $134,453.76. Following the completion of the sale, the chief executive officer now owns 1,283,362 shares of the company's stock, valued at $4,209,427.36. This trade represents a 3.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.February 12, 2025 | marketbeat.comNews Flash: Analysts Just Made A Stunning Upgrade To Their Neuronetics, Inc. (NASDAQ:STIM) ForecastsFebruary 11, 2025 | finance.yahoo.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)February 7, 2025 | globenewswire.comNeuronetics Shares Drop After $18M Offering PricedFebruary 7, 2025 | marketwatch.comNeuronetics prices 8M shares at $2.25 in underwritten public offeringFebruary 7, 2025 | markets.businessinsider.comNeuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common StockFebruary 7, 2025 | finance.yahoo.comNeuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common StockFebruary 7, 2025 | globenewswire.comNeuronetics announces public stock offeringFebruary 6, 2025 | msn.comNeuronetics announces common stock offering, no amount givenFebruary 6, 2025 | markets.businessinsider.comNeuronetics Announces Launch of Underwritten Public Offering of Common StockFebruary 6, 2025 | globenewswire.comWhy Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025February 3, 2025 | msn.comNeuroStar Unveils Two Significant Publications on TMS Therapy for DepressionJanuary 29, 2025 | globenewswire.com Remove Ads Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address STIM Media Mentions By Week STIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STIM News Sentiment▼0.440.80▲Average Medical News Sentiment STIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STIM Articles This Week▼12▲STIM Articles Average Week Remove Ads Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MDXG News Today AORT News Today EYE News Today ESTA News Today AXGN News Today EMBC News Today IRMD News Today BVS News Today BFLY News Today RXST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STIM) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
